Resultados de la búsqueda 91-100 of 12883 for macular degeneration
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
... disease and factors that may determine disease progression and treatment response. ... InPACT-neoadjuvant patients are stratified by disease burden as ...
The Mayo Clinic Upper Digestive Disease Survey has been created in order to have a consistent evaluation tools for patients undergoing esophageal reconstruction ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. ... disease and factors that may determine disease ...
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from ...
Certain conditions also are better seen without contrast. Some people have health conditions that might make using contrast risky, such as kidney disease. In ...
... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...
Rochester, Minn. This study aims to investigate the utility of using plasma DNA methylation to detect measurable residual disease or early recurrence/ ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?